BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is announc...

November 03, 2022 | News

Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery

The operation was performed by the team of Professor and Dr. Xiaofeng Zhang, vice president of Hangzhou First People's Hospital and director of the Ce...

November 03, 2022 | News

WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China

The facility's design incorporates environmental protection, energy conservation, emission reduction, and resource utilization – a reflection of WuXi...

October 26, 2022 | News

Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging

The IND application was submitted in partnership with Grand Pharmaceutical Group Limited (Grand Pharma), Telix's partner in the Greater China reg...

October 17, 2022 | News

Kira Pharmaceuticals Announces IND Approval from Chinese NMPA

Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today th...

October 17, 2022 | News

Merck to Support Jacobio Pharma on Clinical Trial of JAB-21822 in Combination with Cetuximab

This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer. Jacobio ...

October 13, 2022 | News

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...

October 12, 2022 | News

China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers

Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...

October 10, 2022 | News

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...

October 10, 2022 | News

Concord Medical Announces Changes in Management

Mr. Yaw Kong Yap has stepped down from his role as the chief financial officer and president of the Company due to reaching retirement age, effec...

October 03, 2022 | News

WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO), held a topping-off ceremony, i...

September 29, 2022 | News

Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

The investigational new drug (IND) application was submitted by Telix's partner in the Greater China region, Grand Pharmaceutical Group Limited (...

September 28, 2022 | News

Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit

More than 600 participants from about 300 companies, including pharmaceutical manufacturers and retailers as well as logistics companies that handle pharma...

September 27, 2022 | News

Antibiotics Markets in China: Demand to Grow by 9% by 2031

China's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chine...

September 26, 2022 | News

Stay Connected